Zydus Lifesciences has informed that it enclosed a disclosure in prescribed Form ‘C’ under regulation 7(2) of Insider Trading Regulations, received from Zydus Family Trust, Promoter of the Company with respect to sale of 5,83,000 Equity Shares of Re 1 each in the open market. The said sale is to enable the Company to comply with the requirements of minimum public shareholding as mandated under rule 19(2)(b) and 19(A) of Securities Contracts (Regulation) Rules, 1957 and regulation 38 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1679.85 |
| Dr. Reddys Lab | 1333.05 |
| Cipla | 1305.85 |
| Zydus Lifesciences | 947.10 |
| Lupin | 2340.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: